Millennium Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-100,500
| Closed | -$1.32K | – | 6664 |
|
|
2024
Q3 | $1.32K | Hold |
100,500
| – | – | ﹤0.01% | 5977 |
|
|
2024
Q2 | $4.23K | Hold |
100,500
| – | – | ﹤0.01% | 5688 |
|
|
2024
Q1 | $5.23K | Hold |
100,500
| – | – | ﹤0.01% | 6000 |
|
|
2023
Q4 | $5.03K | Hold |
100,500
| – | – | ﹤0.01% | 5821 |
|
|
2023
Q3 | $22.1K | Hold |
100,500
| – | – | ﹤0.01% | 5626 |
|
|
2023
Q2 | $13.1K | Hold |
100,500
| – | – | ﹤0.01% | 5717 |
|
|
2023
Q1 | $4K | Hold |
100,500
| – | – | ﹤0.01% | 6173 |
|
|
2022
Q4 | $5K | Hold |
100,500
| – | – | ﹤0.01% | 6305 |
|
|
2022
Q3 | $6K | Buy |
100,500
+500
| +0.5% | +$30 | ﹤0.01% | 6774 |
|
|
2022
Q2 | $9K | Hold |
100,000
| – | – | ﹤0.01% | 6702 |
|
|
2022
Q1 | $36K | Buy |
+100,000
| New | +$44.1K | ﹤0.01% | 6492 |
|